An extra 229,000 deaths: Is that the cost of US-UK drugs deal?

Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain’s National Health Service (NHS).

In December, the UK and US signed a pharmaceutical trade deal, under which the US government agreed not to impose tariffs on UK pharmaceutic...